BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 9083792)

  • 1. Aripiprazole, a novel antipsychotic drug, inhibits quinpirole-evoked GTPase activity but does not up-regulate dopamine D2 receptor following repeated treatment in the rat striatum.
    Inoue A; Miki S; Seto M; Kikuchi T; Morita S; Ueda H; Misu Y; Nakata Y
    Eur J Pharmacol; 1997 Feb; 321(1):105-11. PubMed ID: 9083792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential effects on D2 dopamine receptor and prolactin gene expression by haloperidol and aripiprazole in the rat pituitary.
    Inoue A; Seto M; Sugita S; Hide I; Hirose T; Koga N; Kikuchi T; Nakata Y
    Brain Res Mol Brain Res; 1998 Apr; 55(2):285-92. PubMed ID: 9582438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Partial agonist properties of the antipsychotics SSR181507, aripiprazole and bifeprunox at dopamine D2 receptors: G protein activation and prolactin release.
    Cosi C; Carilla-Durand E; Assié MB; Ormiere AM; Maraval M; Leduc N; Newman-Tancredi A
    Eur J Pharmacol; 2006 Mar; 535(1-3):135-44. PubMed ID: 16554049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of repeated and acute aripiprazole or haloperidol treatment on dopamine synthesis in the dorsal striatum of young rats: comparison to adult rats.
    Der-Ghazarian T; Charntikov S; Varela FA; Crawford CA; McDougall SA
    J Neural Transm (Vienna); 2010 May; 117(5):573-83. PubMed ID: 20372943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antagonistic effects of OPC-14597, a novel antipsychotic drug, on quinpirole- and (-)-sulpiride-induced changes in evoked dopamine release in rat striatal slices.
    Yamada S; Harano M; Yokoo H; Tanaka M
    J Pharm Pharmacol; 1997 Feb; 49(2):206-8. PubMed ID: 9055196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aripiprazole, a novel antipsychotic, is a high-affinity partial agonist at human dopamine D2 receptors.
    Burris KD; Molski TF; Xu C; Ryan E; Tottori K; Kikuchi T; Yocca FD; Molinoff PB
    J Pharmacol Exp Ther; 2002 Jul; 302(1):381-9. PubMed ID: 12065741
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of dopamine supersensitivity in rats after chronic administration of blonanserin: Comparison with haloperidol.
    Hashimoto T; Baba S; Ikeda H; Oda Y; Hashimoto K; Shimizu I
    Eur J Pharmacol; 2018 Jul; 830():26-32. PubMed ID: 29684390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo actions of aripiprazole on serotonergic and dopaminergic systems in rodent brain.
    Bortolozzi A; Díaz-Mataix L; Toth M; Celada P; Artigas F
    Psychopharmacology (Berl); 2007 Apr; 191(3):745-58. PubMed ID: 17265076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Repeated aripiprazole treatment causes dopamine D2 receptor up-regulation and dopamine supersensitivity in young rats.
    Varela FA; Der-Ghazarian T; Lee RJ; Charntikov S; Crawford CA; McDougall SA
    J Psychopharmacol; 2014 Apr; 28(4):376-86. PubMed ID: 24045880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of chronic treatment with a novel aryl-piperazine antipsychotic on monoamine receptors in rat brain.
    Shapiro LA; Offord SJ; Ordway GA
    Brain Res; 1995 Apr; 677(2):250-6. PubMed ID: 7552250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of SM-9018, a novel 5-HT2 and D2 receptor antagonist, on electrically-evoked [3H]acetylcholine release from rat striatal slices.
    Ishida K; Ohno Y; Ishibashi T; Nakamura M
    Gen Pharmacol; 1996 Oct; 27(7):1203-7. PubMed ID: 8981068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aripiprazole differentially affects mesolimbic and nigrostriatal dopaminergic transmission: implications for long-term drug efficacy and low extrapyramidal side-effects.
    Han M; Huang XF; Deng C
    Int J Neuropsychopharmacol; 2009 Aug; 12(7):941-52. PubMed ID: 19203411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological blockade of dopamine D2 receptors by aripiprazole is not associated with striatal sensitization.
    Koener B; Goursaud S; Van De Stadt M; Calas AG; Jeanjean AP; Maloteaux JM; Hermans E
    Naunyn Schmiedebergs Arch Pharmacol; 2011 Jan; 383(1):65-77. PubMed ID: 21061116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 7-(4-[4-(2,3-Dichlorophenyl)-1-piperazinyl]butyloxy)-3,4-dihydro-2(1H)-quinolinone (OPC-14597), a new putative antipsychotic drug with both presynaptic dopamine autoreceptor agonistic activity and postsynaptic D2 receptor antagonistic activity.
    Kikuchi T; Tottori K; Uwahodo Y; Hirose T; Miwa T; Oshiro Y; Morita S
    J Pharmacol Exp Ther; 1995 Jul; 274(1):329-36. PubMed ID: 7616416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered dopamine D2-like receptor binding in rats with behavioral sensitization to quinpirole: effects of pre-treatment with Ro 41-1049.
    Culver KE; Szechtman H; Levant B
    Eur J Pharmacol; 2008 Sep; 592(1-3):67-72. PubMed ID: 18644362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The selective mGlu(5) receptor agonist CHPG inhibits quinpirole-induced turning in 6-hydroxydopamine-lesioned rats and modulates the binding characteristics of dopamine D(2) receptors in the rat striatum: interactions with adenosine A(2a) receptors.
    Popoli P; Pèzzola A; Torvinen M; Reggio R; Pintor A; Scarchilli L; Fuxe K; Ferré S
    Neuropsychopharmacology; 2001 Oct; 25(4):505-13. PubMed ID: 11557164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dissociation between in vivo occupancy and functional antagonism of dopamine D2 receptors: comparing aripiprazole to other antipsychotics in animal models.
    Natesan S; Reckless GE; Nobrega JN; Fletcher PJ; Kapur S
    Neuropsychopharmacology; 2006 Sep; 31(9):1854-63. PubMed ID: 16319908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [How do antipsychotics exert their effects on dopamine receptor subtypes?].
    Inoue A; Nakata Y
    Nihon Yakurigaku Zasshi; 1998 Dec; 112(6):351-61. PubMed ID: 10202760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. D2 dopamine receptors and modulation of spontaneous acetylcholine (ACh) release from rat striatal synaptosomes.
    Clos MV; García-Sanz A; Vivas NM; Badia A
    Br J Pharmacol; 1997 Sep; 122(2):286-90. PubMed ID: 9313937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aripiprazole has functionally selective actions at dopamine D2 receptor-mediated signaling pathways.
    Urban JD; Vargas GA; von Zastrow M; Mailman RB
    Neuropsychopharmacology; 2007 Jan; 32(1):67-77. PubMed ID: 16554739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.